Main Street Research’s Gilead Sciences GILD Stock Holding History

Main Street Research’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,829	Closed	-$224K	–	151
2025 Q4	$224K	Buy	+1,829	New	+$222K	0.01%	126
2024 Q1	–	Sell	-2,604	Closed	-$211K	–	115
2023 Q4	$211K	Buy	+2,604	New	+$203K	0.02%	100
2023 Q3	–	Sell	-2,604	Closed	-$201K	–	96
2023 Q2	$201K	Hold	2,604	–	–	0.03%	90
2023 Q1	$216K	Sell	2,604 -85	-3%	-$7.04K	0.04%	86
2022 Q4	$231K	Buy	+2,689	New	+$213K	0.06%	87
2022 Q1	–	Sell	-3,469	Closed	-$252K	–	125
2021 Q4	$252K	Sell	3,469 -1,518	-30%	-$105K	0.02%	122
2021 Q3	$348K	Buy	+4,987	New	+$350K	0.03%	96
2020 Q4	–	Sell	-3,334	Closed	-$211K	–	130
2020 Q3	$211K	Sell	3,334 -189,743	-98%	-$13.2M	0.03%	106
2020 Q2	$14.9M	Buy	193,077 +9,264	+5%	+$710K	2.33%	19
2020 Q1	$13.7M	Buy	183,813 +176,864	+2,545%	+$12.2M	3.37%	8
2019 Q4	$452K	Buy	6,949 +6	+0.1%	+$391	0.07%	64
2019 Q3	$440K	Buy	6,943 +606	+10%	+$39.6K	0.08%	62
2019 Q2	$428K	Sell	6,337 -160	-2%	-$10.5K	0.1%	62
2019 Q1	$422K	Sell	6,497 -905	-12%	-$60.2K	0.13%	59
2018 Q4	$463K	Buy	7,402 +905	+14%	+$63.3K	0.18%	45
2018 Q3	$502K	Sell	6,497 -231	-3%	-$17.4K	0.07%	67
2018 Q2	$477K	Sell	6,728 -1,000	-13%	-$70.6K	0.07%	68
2018 Q1	$583K	Buy	7,728 +361	+5%	+$28.7K	0.09%	61
2017 Q4	$528K	Buy	7,367 +950	+15%	+$72.1K	0.08%	68
2017 Q3	$520K	Buy	6,417 +17	+0.3%	+$1.3K	0.08%	72
2017 Q2	$453K	Sell	6,400 -24,014	-79%	-$1.6M	0.07%	86
2017 Q1	$2.07M	Sell	30,414 -32,624	-52%	-$2.29M	0.36%	56
2016 Q4	$4.51M	Buy	63,038 +3,760	+6%	+$279K	0.88%	47
2016 Q3	$4.69M	Buy	59,278 +1,035	+2%	+$84.1K	0.92%	49
2016 Q2	$4.86M	Sell	58,243 -168	-0.3%	-$14.9K	1%	41
2016 Q1	$5.37M	Sell	58,411 -506	-0.9%	-$45.6K	1.38%	32
2015 Q4	$5.96M	Buy	58,917 +1,365	+2%	+$142K	1.27%	37
2015 Q3	$6.22M	Buy	57,552 +3,552	+7%	+$394K	1.46%	30
2015 Q2	$6.32M	Buy	54,000 +7,551	+16%	+$825K	1.29%	35
2015 Q1	$4.56M	Buy	46,449 +3,383	+8%	+$344K	0.98%	41
2014 Q4	$4.06M	Sell	43,066 -40,826	-49%	-$4.22M	0.87%	49
2014 Q3	$8.93M	Sell	83,892 -1,320	-2%	-$129K	1.99%	5
2014 Q2	$7.07M	Buy	85,212 +4,394	+5%	+$342K	1.67%	15
2014 Q1	$5.73M	Buy	80,818 +1,891	+2%	+$148K	1.39%	29
2013 Q4	$5.93M	Sell	78,927 -170	-0.2%	-$11.8K	1.48%	22
2013 Q3	$4.97M	Sell	79,097 -1,555	-2%	-$92.9K	1.34%	29
2013 Q2	$4.13M	Buy	+80,652	New	+$4.2M	1.25%	30

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Main Street Research's GILD Position: Q1 2026 in Review

Main Street Research sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 1,829 shares — an estimated $224K sold.

Main Street Research first reported a position in GILD in Q2 2013 and held it in 37 quarters. The position peaked at $14.9M in Q2 2020. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Main Street Research reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
Main Street Research sold 1,829 Gilead Sciences shares in Q1 2026, an estimated $224K.
Main Street Research first reported a position in Gilead Sciences in Q2 2013 and held it in 37 quarters.
Main Street Research's Gilead Sciences position peaked at $14.9M in Q2 2020.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Main Street Research's 13F filing for Q1 2026, filed 30 Apr 2026.